Skip to content
Screener

Septerna, Inc. SEPN Total Liabilities

Total Liabilities at other companies

Amgen logo
AmgenAMGN
$937M-15.5%
Tectonic Therapeutics logo
Tectonic TherapeuticsTECX
$16.16M+17.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$48.4M-14.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$36.06M+64.0%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$132.91M-7.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$37.86M-7.2%

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.78B+240%
Enterprise value$1.73B+383%
P/S24.7×-696×

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The source filing: Septerna, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:08 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216759
Line itemMarch 31, 2026December 31, 2025
Deferred revenue, non-current92,184105,917
Operating lease liabilities, non-current20,78121,413
Other non-current liabilities100
Total liabilities191,230214,261
Commitments and contingencies (Note 5)
Stockholders' equity:
Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value per share, 500,000,000 shares authorized at March 31, 2026 and December 31, 2025; 44,916,572 and 44,806,272 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively; 75,247 and 131,224 shares subject to repurchase as of March 31, 2026 and December 31, 2025, respectively4545

Item 1. Condensed Financial Statements.

FAQ

What is Septerna, Inc.'s total liabilities?
Septerna, Inc. (SEPN) reported total liabilities of $191.23M in Q1 2026.
How has Septerna, Inc.'s total liabilities changed year-over-year?
Septerna, Inc.'s total liabilities increased by 466.5% year-over-year, from $33.75M to $191.23M.
What is the long-term trend for Septerna, Inc.'s total liabilities?
Over 2 years (2023 to 2025), Septerna, Inc.'s total liabilities has grown at a 227.1% compound annual growth rate (CAGR), from $20.03M to $214.26M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.

Ask your AI about Septerna, Inc.'s total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude